US medical device makers decline after reciprocal tariffs on China, Mexico

Shares of U.S. medical device makers decline between 1% and 3.5% premarket

GE Healthcare GEHC.O and glucose monitor manufacturer Dexcom DXCM.O both decline 3% each

President Donald Trump imposed an additional 34% tariff on China, 20% tariff on EU and 25% tariff for some goods from Canada and Mexico

Tariffs imposed on these geographies could hurt R&D spending, availability of certain devices and cause supply chain disruptions for these device manufacturers, Citi analysts wrote in a note

Some firms such as Boston Scientific BSX.N and GEHC have accounted for impact of tariffs in their fiscal 2025 guidance, while others such as Abbot ABT.N and DXCM have not

Shares of medical device firms Abbott ABT.N and Boston Scientific BSX.N also fall over 1% before the bell

As of last close, ABT up ~17%, BSX up 12% and GEHC up 1.5%, while DXCM down 12.4% YTD

S&P 500 Health Care Equipment sub index .SPLRCMED is up 5.4% so far this year